StockNews.AI
BHC
StockNews.AI
111 days

Bausch Health Announces First Quarter 2025 Results

1. Bausch Health reports 5% revenue growth and plans asset value optimization. 2. Company maintains full-year guidance despite $58 million net loss.

Earnings
0%Current Return
VS
+0.76%S&P 500
$5.304/30 04:19 PM EDTEvent Start
$5.305/01 11:17 PM EDTLatest Updated
3m saved
Insight
Article

FAQ

Why Bullish?

Positive revenue growth and continuous improvement in adjusted EBITDA support future optimism. Historically, strong financial performance has led to increased investor confidence in BHC.

How important is it?

The article provides key financial metrics indicating BHC's strong performance and strategic focus, which could influence investor sentiment significantly.

Why Short Term?

The immediate impact of the revenue growth and refinancing will likely be seen in the next quarter. Previous instances show that quarterly earnings directly influence short-term stock movements.

Related Companies

BHCCVSJNJ
First Quarter Consolidated Revenues of $2.26 billion, up 5% on a Reported basis and 6% on an Organic (non-GAAP) 1 basis over the prior year period GAAP Net Loss Attributable to Bausch Health Companies of $58 million and GAAP Net Loss of $86 million Consolidated Adjusted EBITDA Attributable to Bausch Health Companies (non-GAAP) 1 of $661 million, in line with prior year period BAUSCH HEALTH EXCLUDING BAUSCH + LOMB FIRST QUARTER 2025 RESULTS Eighth consecutive quarter of year-over-year Revenue and Adjusted EBITDA (non-GAAP) 1 growth, with 6% and 14% growth versus the prior year period, respectively With strong financial momentum, remain committed to evaluating all options to unlock shareholder value, including maximizing the value of assets and share buybacks Successfully completed $7.9B refinancing in early April to extend near- and medium- term maturities Received favorable ruling from D.C. District Court in Norwich's case against the FDA Maintaining full-year 2025 Revenue and Adjusted EBITDA (non-GAAP) 1 guidance, with Adjusted Cash Flow from Operations (non-GAAP) 1 guidance updated primarily to reflect higher interest expense LAVAL, QC / ACCESS Newswire / April 30, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) ("Bausch Health" or the "Company" or "we" or "our") today announced its first quarter 2025 financial results and other key updates from the quarter.

Related News